|
|
Vaccine Detail
|
P501-AS15 vaccine |
| Vaccine Information |
- Vaccine Name: P501-AS15 vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: CPC-P501 Protein (NCT00148928)
- Immunization Route: Other
- Description: This vaccine is made up of CPC-P501 protein formulated with the adjuvant AS15. Patients with hormone-sensitive prostate cancer and rising PSA, after primary tumor treatment, can be treated with the P501-AS15 vaccine. (NCT00148928)
|
| Host Response |
|
|
| References |
NCT00148928: Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA [https://clinicaltrials.gov/study/NCT00148928]
|
|
